Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BOLD
일자시간출처헤드라인심볼기업
2018/01/2508:45Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)NASDAQ:BOLDBoundless Bio Inc
2018/01/2406:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/01/2406:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:BOLDBoundless Bio Inc
2018/01/2406:01PR Newswire (US)Audentes Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:BOLDBoundless Bio Inc
2018/01/2007:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/01/0421:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/01/0421:00PR Newswire (US)Audentes Announces Positive Interim Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients Wi...NASDAQ:BOLDBoundless Bio Inc
2018/01/0322:00PR Newswire (US)Audentes Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
2017/12/1408:30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BOLDBoundless Bio Inc
2017/12/1406:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2017/12/1322:00PR Newswire (US)Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of DirectorsNASDAQ:BOLDBoundless Bio Inc
2017/12/0606:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/2122:00PR Newswire (US)Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-L...NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/11/1807:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2017/11/1622:00PR Newswire (US)Audentes Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
2017/11/1507:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BOLDBoundless Bio Inc
2017/11/1507:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
2017/11/1507:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2017/11/1506:01PR Newswire (US)Audentes Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
2017/11/1316:00PR Newswire (US)Audentes Therapeutics Announces MHRA Approval of Clinical Trial Authorisation Application for AT342 to Treat Crigler-Najjar S...NASDAQ:BOLDBoundless Bio Inc
2017/11/0722:00PR Newswire (US)Audentes Therapeutics to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 14, 2...NASDAQ:BOLDBoundless Bio Inc
2017/10/1107:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2017/10/1107:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
 검색 관련기사 보기:NASDAQ:BOLD